← Insider buys

FREQ

Frequency Therapeutics, Inc.

No insider bought or sold Frequency Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

FREQ over the last year

Prices for FREQ aren't in yet.

FREQ after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

50 insider filings since 2019, newest first

FREQSell

David L. Lucchino · President and CEO

$475K−3.0%Mar 2
FREQSell

David L. Lucchino · President and CEO

$910K−5.0%Feb 10
FREQSell

David L. Lucchino · President and CEO

$538K−3.0%Feb 5
FREQSell

David L. Lucchino · President and CEO

$254K−2.0%Feb 4
FREQSell

David L. Lucchino · President and CEO

$1.4M−10.0%Feb 3
FREQSell

Christopher R. Loose · Chief Scientific Officer

$455K−31.0%Feb 3
FREQSell

David L. Lucchino · President and CEO

$391K−3.0%Jan 28
FREQSell

Christopher R. Loose · Chief Scientific Officer

$340K−20.0%Jan 28
FREQSell

David L. Lucchino · President and CEO

$1.1M−8.0%Jan 8
FREQSell

David L. Lucchino · President and CEO

$1.1M−10.0%Jan 6
FREQSell

Joel S Marcus · Director

$1.7M−4.0%Dec 22
FREQSell

David L. Lucchino · President and CEO

$48KDec 21
FREQSell

Christopher R. Loose · Chief Scientific Officer

$325K−17.0%Dec 17
FREQSell

David L. Lucchino · President and CEO

$1.5M−11.0%Dec 16
FREQSell

Christopher R. Loose · Chief Scientific Officer

$890K−33.0%Dec 16
FREQSell

David L. Lucchino · President and CEO

$445K−4.0%Dec 10
FREQSell

David L. Lucchino · President and CEO

$417K−4.0%Dec 9
FREQSell

David L. Lucchino · President and CEO

$439K−5.0%Dec 3
FREQSell

Christopher R. Loose · Chief Scientific Officer

$376K−18.0%Nov 9
FREQSell

David L. Lucchino · President and CEO

$327K−4.0%Nov 3
FREQSell

Christopher R. Loose · Chief Scientific Officer

$176K−8.0%Oct 14
FREQSell

Christopher R. Loose · Chief Scientific Officer

$485K−20.0%Oct 8
FREQSell

Christopher R. Loose · Chief Scientific Officer

$449K−17.0%Oct 5
FREQSell

David L. Lucchino · President and CEO

$301K−4.0%Oct 5
FREQSell

Christopher R. Loose · Chief Scientific Officer

$95K−3.0%Sep 25
FREQSell

Christopher R. Loose · Chief Scientific Officer

$85K−3.0%Sep 10
FREQSell

David L. Lucchino · President and CEO

$291K−4.0%Sep 3
FREQSell

Christopher R. Loose · Chief Scientific Officer

$103K−3.0%Aug 20
FREQSell

Christopher R. Loose · Chief Scientific Officer

$95K−3.0%Aug 6
FREQSell

David L. Lucchino · President and CEO

$340K−4.0%Aug 5
FREQSell

Christopher R. Loose · Chief Scientific Officer

$97K−3.0%Jul 23
FREQSell

Christopher R. Loose · Chief Scientific Officer

$100K−3.0%Jul 10
FREQSell

David L. Lucchino · President and CEO

$353K−4.0%Jul 2
FREQSell

Christopher R. Loose · Chief Scientific Officer

$103K−3.0%Jun 25
FREQSell

Christopher R. Loose · Chief Scientific Officer

$90K−3.0%Jun 12
FREQSell

David L. Lucchino · President and CEO

$71K−1.0%Jun 4
FREQSell

David L. Lucchino · President and CEO

$213K−3.0%Jun 2
FREQSell

Joel S Marcus · Director

$94KMay 22
FREQSell

Christopher R. Loose · Chief Scientific Officer

$86K−2.0%May 22
FREQSell

Joel S Marcus · Director

$525K−2.0%May 20
FREQSell

David L. Lucchino · President and CEO

$190K−2.0%May 12
FREQSell

Christopher R. Loose · Chief Scientific Officer

$73K−2.0%May 7
FREQSell

David L. Lucchino · President and CEO

$85K−1.0%May 7
FREQSell

David L. Lucchino · President and CEO

$80K−1.0%May 4
FREQSell

Christopher R. Loose · Chief Scientific Officer

$67K−2.0%Apr 24
FREQSell

David L. Lucchino · President and CEO

$50K−1.0%Apr 21
FREQSell

David L. Lucchino · President and CEO

$79K−1.0%Apr 17
FREQSell

Christopher R. Loose · Chief Scientific Officer

$67K−2.0%Apr 10
FREQBuy

Marc A Cohen · Director

$250K+3.0%Oct 8
FREQBuy

James E Flynn · Possible Member of 10% Group, 10%

$4.0M+30.0%Oct 7

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.